Position in INMB
as of Jun 30, 2026
· filed Aug 18, 2026
Position Value
$16,899
+$5,184 QoQ
Shares Held
10,368
0.0% QoQ
Ownership
0.037%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#49
of 83 holders
Holding Since
Sep 2023
10 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in INMB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Beacon Pointe Advisors, LLC holds $41,283,927 across 27 Biotechnology names. INMB ranks #25 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
19,460 | $12,134,088 | |
| 2 | INCY |
Incyte Corp
|
84,502 | $9,579,146 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
17,047 | $8,467,756 | |
| 4 | NUVB |
Nuvation Bio Inc.
|
632,251 | $3,591,185 | |
| 5 | SMMT |
Summit Therapeutics Inc.
|
98,114 | $1,429,520 | |
| 6 | BNTX |
BioNTech SE
|
13,199 | $1,228,166 | |
| 7 | IBRX |
ImmunityBio, Inc.
|
73,497 | $643,466 | |
| 8 | CRSP |
CRISPR Therapeutics AG
|
11,307 | $616,683 |
All Filings in INMB
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,899 | 10,368 | Shares | Sole | 2026-08-18 | |
| 2026-03-31 | $11,715 | 10,368 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $16,174 | 10,368 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $21,461 | 10,368 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $23,950 | 10,368 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $80,974 | 10,368 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $48,418 | 10,368 | Shares | Sole | 2025-02-14 | |
| 2024-03-31 | $121,824 | 10,368 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $116,743 | 10,368 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $70,191 | 10,368 | Shares | Sole | 2023-11-14 | |
| No filing history on record for this holder in this stock. | ||||||